Schedule 13G ownership disclosure
Twist Bioscience Corp
COMMON STOCK · CUSIP: 90184D100
Event date: 2024-12-31
- Filing-level shares
- 2,543,997.00
- Percent of class
- 4.3%
- STATE STREET CORPORATION
Shares: 2,543,997.00 · Class: 4.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-25-000087
- Form type
- SCHEDULE 13G
- Filer
- STATE STREET CORP
- CIK
- CIK 93751
- Filed
- Feb 05, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership